Pramiracetam

Pramiracetam
Clinical data
Routes of; administration	Oral
Legal status
Legal status	Unscheduled (US);
Identifiers
	IUPAC name N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide;
PubChem CID	51712;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C14H27N3O2
Molar mass	269.383 g/mol
3D model (JSmol)	Interactive image;
	SMILES CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C;

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Pramiracetam is a nootropic drug derived from piracetam, and is more potent (i.e. lower dosage is used). It belongs to the racetam family of nootropics.

Pramiracetam was developed by Parke-Davis based on Piracetam, and is 8-30 times stronger than Piracetam. It goes by the trade name Neupramir or Pramistar.

External links

James South, Nootropics - Reviewing The Smart-Drugs
The Cognitive Enhancement Research Institute

Template:Racetams Template:Psychostimulants, agents used for ADHD and nootropics Template:Pharma-stub

de:Pramiracetam fi:Pramirasetaami

Clinical data


Routes of administration	Oral
Legal status
Legal status	Unscheduled (US)
Identifiers
IUPAC name N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
PubChem CID	51712
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₄H₂₇N₃O₂
Molar mass	269.383 g/mol
3D model (JSmol)	Interactive image
SMILES CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C

Pramiracetam

External links

Navigation menu